Dependence of changes in hematological and integrative parameters in patients with chronic viral hepatitis C on the received antiviral therapy

A. H. Lishnevska, M. D. Chemych



A total of 287 patients were treated with various antiviral therapy options: group I – basic (pathogenetic and symptomatic) therapy, group II – pegylated interferon in combination with ribavirin, group III – pegylated interferon with ribavirin and sofosbuvir, group IV – direct-acting antivirals. Patients with chronic viral hepatitis C (CVHC) before the start of treatment showed a decrease in platelet counts, segmented neutrophils and an increase in level of lymphocytes, bilirubin content, alanine aminotransferase activity, aspartate, transferrinase (practice), with a comparison group (practically virus-free patients) <0.05. After 4 weeks of receiving interferon-containing therapy, a further decrease was observed: leukocyte count, erythrocyte count, platelet count; ALT, AST and gamma-glutamyltranspeptidase (GGTP) activity; increased erythrocyte sedimentation rate (ESR), bilirubin content, and bilirubin activity p< 0.05. Patients who received direct-acting antivirals (DAAs) had a decrease in: erythrocyte count, total bilirubin content, ALT activity, AST, GGTP; increase in sed rate and the AST/ALT ratio, p <0.05. After 12 weeks of treatment, patients treated with pegylated interferon were diagnosed with a decrease in platelet count, erythrocyte count, and leukocyte count (with the exception of patients with dual therapy that experienced the slight increase of the leukocytes) with hemoglobin content, p <0.05. Also, in the group II subjects compared with week 4 decreased: the content of bilirubin and creatinine, the activity of ALT, AST, GGTP, while the De Ritis ratio increased (p <0.05). Patients in group III had lower GGTP activity than at 4 weeks and lower ALT and AST values compared with the onset of  antiviral therapy (p <0.05). Patients receiving DAAs experienced a decrease in hemoglobin content; no changes in biochemical parameters at this stage compared with the previous one were established.

The investigated integrative indicators suggest changes in the immune system of patients, in particular the prevalence of cellular immunity over the humoral link and the predominance of the autoimmune component. Patients with dual and triple PVT regimens had more pronounced changes compared to patients receiving DAAs.


chronic viral hepatitis C; clinical blood test; biochemical blood test; integrative parameters; immunity

Full Text:



Hepatitis C [Electronic resource] // World Health Organization. - 2019. - Resource Access Mode:

McCarthy J. J. Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin / J. J. McCarthy, J. H. Li, A. Thompson [et al.] // J. Gastroenterology. – 2010. – №6. – P. 2307–2314.

Pawlotsky, Jean-Micheletal. EASL Recommendations onTreatment of Hepatitis C 2018. Journal of Hepatology, Volume 69, Issue 2, 461 – 511.

Estes C, Abdel-Kareem M, Abdel-Razek W, etal. Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies. Aliment Pharmacol Ther 2015;42(6):696–706.

Wittenborn J, Brady J, Dougherty M, etal. Potential epidemiologic, economic, and budgetary impacts of current rates of hepatitis C treatment in Medicare and non-Medicare populations. Hepatol Commun 2017;1(2):99–109.

VanderMeer AJ, Veldt BJ, Feld JJ, Wedemeyer H, Dufour JF, Lammert F, etal. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA 2012;308:2584–2593.

Bruno S, DiMarco V, Iavarone M, Roffi L, Crosignani A, Calvaruso V, etal. Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population. J Hepatol 2016;64:1217–1223

Nahon P, Bourcier V, Layese R, Audureau E, Cagnot C, Marcellin P, etal. Eradication of hepatitis C virus in fection in patients with cirrhos is reduces risk of liver and non-liver complications. Gastroenterology 2017;152:142–156, e2

Salomone F, Catania M, Montineri A, Bertino G, Godos J, Rizzo L, Magrì G, LiVolti G. Hepatitis C viruse radication by direct antiviral agents improves glucose tolerance and reduces post-load insulin resistance in nondiabetic patients with genotype 1. Liver Int [Internet]. 2018;38(7):1206-11. Available from:

Vukovic VR, Baskic D, Mijailovic Z, Djurdjevic P, Jovanovic D, Mitrovic S, Popovic S, Popovski-Jovicic B. Hepatitis C therapy-related haematological side effects are associated with treatment outcome. Serb J Exp Clin Res [Internet]. 2016;17(1):9-14. Available from:

Sulkowski MS, Wasserman R, Brooks L etal. Changes in hemoglobin during interferon alfa-2b plus ribavirin combination therapy for chronic hepatitis C virus infection. J Viral Hepat 2004; 11: 243-50.

Sulkowski M. Management of the hematologic complications of hepatitis C therapy. Clin Liver Dis 2005; 9:601-16.

Soza A, Everhart JE, Ghany MG etal. Neutropenia during combination therapy of interferon alpha and ribavirin for chronic hepatitis C. Hepatology 2002; 36: 1273-9.

Elsharkawy A, Eletreby R, Fouad R, Soliman Z, Abdallah M, Negm M, Mohey M, Esmat G. Impact of differents of osbuvirbased treatment regimens on the biochemical profile of chronic hepatitis C genotype 4 patients. Expert Rev Gastroenterol Hepatol [Internet]. 2017;11(8):773-8. Available from:

Hodlevsyi A.A., Savoliuk S.I. Diagnostica ta moniyoring endotoksikosu u khirurgichnikh khvorikh : monografia [Diagnostics of endotoxicosis in surgical patients]. – Vinnitsa : Nova Knyha, 2015. – 232 p.

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM

Journal of Education, Health and Sport formerly Journal of Health Sciences

Declaration on the original version.

Editors indicates that the main version of the magazine is to issue a "electronic".

The journal has had 5 points in Ministry of Science and Higher Education parametric evaluation. § 8. 2) and § 12. 1. 2) 22.02.2019.

1223 Journal of Education, Health and Sport eISSN 2391-8306 7

ISSN 2391-8306 formerly ISSN: 1429-9623 / 2300-665X

Archives 2011 - 2014

PBN 2011 - 2014

POL-index 2011 - 2014

BASE 2011 - 2014

Indexed in Bases, Bazy indeksacyjne: ERIH Plus, Worldcat, PBN/POL-Index, ICI Journals Master List, Directory of Open Access Journals (DOAJ), ZBD, Ulrich's periodicals, Google Scholar, Polska Bibliografia Lekarska, EuroPub database, NLM Catalog Result - NCBI, BASE, Russian Sciences Index, Arianta.

US NLM = 101679844

101679844 - NLM Catalog Result - NCBI

Find a library that holds this journal:


PBN Poland



Redaction, Publisher and Editorial Office

Publisher and Editorial Office
Department of Physical Culture,
Faculty of Earth Sciences and Spatial Management,
Nicolaus Copernicus University in Toruń, Poland
Address: Str. Lwowska 1, 87-100 Toruń, Poland

  Open Access ISSN 2391-8306 formerly ISSN: 1429-9623 / 2300-665X

The journal has been approved for inclusion in ERIH PLUS.

The ERIH PLUS listing of the journal is available at

Indexed in Index Copernicus Journals Master List.,p24782242,3.html

ICV 2018 = 95.95 ICV 2017 = 91.30 ICV 2016 = 84.69 ICV 2015 = 93.34 ICV 2014 = 89.51 Standardized Value: 8.27 ICV 2013: 7.32 ICV 2012: 6.41 ICV 20115.48


Indexed in Polish Scholarly Bibliography (PBN) (PBN Polska Bibliografia Naukowa) (

is a portal of the Polish Ministry of Science and Higher Education, collecting information on publications of Polish scientists and on Polish and foreign scholarly journals. Polish Scholarly Bibliograhpy is a part of POL-on - System of Information on Higher Education. It is operated by the Interdisciplinary Centre for Mathematical and Computational Modelling, University of Warsaw.

Indexed in Russian Sciences Index Российский индекс научного цитирования (РИНЦ)

Indexed in Arianta Polish scientific and professional electronic journals Aneta Drabek i Arkadiusz Pulikowski


Partnerzy platformy czasopism